CTTN and esophageal squamous cell carcinoma: Cortactin is overexpressed in premalignant lesions, early stage dysplasia, and carcinoma in situ of the esophagus; together with Fascin and Survivin, high protein expression levels of Cortactin have been shown to be associated with worse prognosis of patients with ESCC [67, 68].